Literature DB >> 18223668

Comparative study on transduction and toxicity of protein transduction domains.

T Sugita1, T Yoshikawa, Y Mukai, N Yamanada, S Imai, K Nagano, Y Yoshida, H Shibata, Y Yoshioka, S Nakagawa, H Kamada, S-I Tsunoda, Y Tsutsumi.   

Abstract

BACKGROUND AND
PURPOSE: Protein transduction domains (PTDs), such as Tat, antennapedia homeoprotein (Antp), Rev and VP22, have been extensively utilized for intracellular delivery of biologically active macromolecules in vitro and in vivo. There is little known, however, about the relative transduction efficacy, cytotoxicity and internalization mechanism of individual PTDs. EXPERIMENTAL APPROACH: We examined the cargo delivery efficacies of four major PTDs (Tat, Antp, Rev and VP22) and evaluated their toxicities and cell internalizing pathways in various cell lines. KEY
RESULTS: The relative order of the transduction efficacy of these PTDs conjugated to fluorescein was Rev>Antp>Tat>VP22, independent of cell type (HeLa, HaCaT, A431, Jurkat, MOLT-4 and HL60 cells). Antp produced significant toxicity in HeLa and Jurkat cells, and Rev produced significant toxicity in Jurkat cells. Flow cytometric analysis demonstrated that the uptake of PTD-fluorescein conjugate was dose-dependently inhibited by methyl-beta-cyclodextrin, cytochalasin D and amiloride, indicating that all four PTDs were internalized by the macropinocytotic pathway. Accordingly, in cells co-treated with 'Tat-fused' endosome-disruptive HA2 peptides (HA2-Tat) and independent PTD-fluorescent protein conjugates, fluorescence spread throughout the cytosol, indicating that all four PTDs were internalized into the same vesicles as Tat. CONCLUSIONS AND IMPLICATIONS: These findings suggest that macropinocytosis-dependent internalization is a crucial step in PTD-mediated molecular transduction. From the viewpoint of developing effective and safe protein transduction technology, although Tat was the most versatile carrier among the peptides studied, PTDs should be selected based on their individual characteristics.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18223668      PMCID: PMC2275450          DOI: 10.1038/sj.bjp.0707678

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  43 in total

1.  Creation of novel Protein Transduction Domain (PTD) mutants by a phage display-based high-throughput screening system.

Authors:  Yohei Mukai; Toshiki Sugita; Tomoko Yamato; Natsue Yamanada; Hiroko Shibata; Sunao Imai; Yasuhiro Abe; Kazuya Nagano; Tetsuya Nomura; Yasuo Tsutsumi; Haruhiko Kamada; Shinsaku Nakagawa; Shin-ichi Tsunoda
Journal:  Biol Pharm Bull       Date:  2006-08       Impact factor: 2.233

Review 2.  The taming of the cell penetrating domain of the HIV Tat: myths and realities.

Authors:  Ashok Chauhan; Akshay Tikoo; Arvinder K Kapur; Mahavir Singh
Journal:  J Control Release       Date:  2006-11-17       Impact factor: 9.776

3.  Characterisation of cell-penetrating peptide-mediated peptide delivery.

Authors:  Simon W Jones; Richard Christison; Ken Bundell; Catherine J Voyce; Sarah M V Brockbank; Peter Newham; Mark A Lindsay
Journal:  Br J Pharmacol       Date:  2005-08       Impact factor: 8.739

4.  Creation of novel cell-penetrating peptides for intracellular drug delivery using systematic phage display technology originated from Tat transduction domain.

Authors:  Haruhiko Kamada; Takayuki Okamoto; Maki Kawamura; Hiroko Shibata; Yasuhiro Abe; Akiko Ohkawa; Tetsuya Nomura; Masaki Sato; Yohei Mukai; Toshiki Sugita; Sunao Imai; Kazuya Nagano; Yasuo Tsutsumi; Shinsaku Nakagawa; Tadanori Mayumi; Shin-ichi Tsunoda
Journal:  Biol Pharm Bull       Date:  2007-02       Impact factor: 2.233

Review 5.  Influence of protein transduction domains on intracellular delivery of macromolecules.

Authors:  Christopher L Murriel; Steven F Dowdy
Journal:  Expert Opin Drug Deliv       Date:  2006-11       Impact factor: 6.648

Review 6.  Mechanistic aspects of CPP-mediated intracellular drug delivery: relevance of CPP self-assembly.

Authors:  Sílvia Pujals; Jimena Fernández-Carneado; Carmen López-Iglesias; Marcelo J Kogan; Ernest Giralt
Journal:  Biochim Biophys Acta       Date:  2006-01-30

7.  Mechanism of the cell-penetrating peptide transportan 10 permeation of lipid bilayers.

Authors:  Lindsay E Yandek; Antje Pokorny; Anders Florén; Kristina Knoelke; Ulo Langel; Paulo F F Almeida
Journal:  Biophys J       Date:  2007-01-11       Impact factor: 4.033

8.  Cell-penetrating peptides: a comparative membrane toxicity study.

Authors:  Külliki Saar; Maria Lindgren; Mats Hansen; Emelía Eiríksdóttir; Yang Jiang; Katri Rosenthal-Aizman; Meeri Sassian; Ulo Langel
Journal:  Anal Biochem       Date:  2005-10-01       Impact factor: 3.365

9.  Cellular uptake of unconjugated TAT peptide involves clathrin-dependent endocytosis and heparan sulfate receptors.

Authors:  Jean Philippe Richard; Kamran Melikov; Hilary Brooks; Paul Prevot; Bernard Lebleu; Leonid V Chernomordik
Journal:  J Biol Chem       Date:  2005-02-01       Impact factor: 5.157

10.  Improved cytosolic translocation and tumor-killing activity of Tat-shepherdin conjugates mediated by co-treatment with Tat-fused endosome-disruptive HA2 peptide.

Authors:  Toshiki Sugita; Tomoaki Yoshikawa; Yohei Mukai; Natsue Yamanada; Sunao Imai; Kazuya Nagano; Yasunobu Yoshida; Hiroko Shibata; Yasuo Yoshioka; Shinsaku Nakagawa; Haruhiko Kamada; Shin-ichi Tsunoda; Yasuo Tsutsumi
Journal:  Biochem Biophys Res Commun       Date:  2007-09-29       Impact factor: 3.575

View more
  17 in total

1.  TAT fusion protein transduction into isolated mitochondria is accelerated by sodium channel inhibitors.

Authors:  Jayanagendra P Rayapureddi; Wendy J Tomamichel; Sonia T Walton; R Mark Payne
Journal:  Biochemistry       Date:  2010-11-09       Impact factor: 3.162

Review 2.  Delivery of macromolecules using arginine-rich cell-penetrating peptides: ways to overcome endosomal entrapment.

Authors:  Ayman El-Sayed; Shiroh Futaki; Hideyoshi Harashima
Journal:  AAPS J       Date:  2009-01-06       Impact factor: 4.009

Review 3.  Transduction of human recombinant proteins into mitochondria as a protein therapeutic approach for mitochondrial disorders.

Authors:  Lefkothea C Papadopoulou; Asterios S Tsiftsoglou
Journal:  Pharm Res       Date:  2011-08-27       Impact factor: 4.200

4.  Efficient transdermal delivery of functional protein cargoes by a hydrophobic peptide MTD 1067.

Authors:  Hee Je Shin; Sun Uk Bak; Ha Na La; Jin Sun Kang; Hwa Hyun Lee; Hyo Jung Eom; Byung Kyu Lee; Hyun Ah Kang
Journal:  Sci Rep       Date:  2022-06-27       Impact factor: 4.996

5.  Intracellular delivery of a proapoptotic peptide via conjugation to a RAFT synthesized endosomolytic polymer.

Authors:  Craig L Duvall; Anthony J Convertine; Danielle S W Benoit; Allan S Hoffman; Patrick S Stayton
Journal:  Mol Pharm       Date:  2010-04-05       Impact factor: 4.939

6.  Efficient protein transduction method using cationic peptides and lipids.

Authors:  Kei Yamaguchi; Mari Inoue; Naoki Goshima
Journal:  J Biomed Biotechnol       Date:  2011-10-09

7.  A Heparan Sulfate-Binding Cell Penetrating Peptide for Tumor Targeting and Migration Inhibition.

Authors:  Chien-Jung Chen; Kang-Chiao Tsai; Ping-Hsueh Kuo; Pei-Lin Chang; Wen-Ching Wang; Yung-Jen Chuang; Margaret Dah-Tsyr Chang
Journal:  Biomed Res Int       Date:  2015-05-03       Impact factor: 3.411

8.  The interaction of mycobacterial protein Rv2966c with host chromatin is mediated through non-CpG methylation and histone H3/H4 binding.

Authors:  Garima Sharma; Sandeep Upadhyay; M Srilalitha; Vinay K Nandicoori; Sanjeev Khosla
Journal:  Nucleic Acids Res       Date:  2015-03-30       Impact factor: 16.971

9.  Transduction of the MPG-tagged fusion protein into mammalian cells and oocytes depends on amiloride-sensitive endocytic pathway.

Authors:  So-Jung Kwon; Kyuyong Han; Suhyun Jung; Jong-Eun Lee; Seongsoon Park; Yong-Pil Cheon; Hyunjung Jade Lim
Journal:  BMC Biotechnol       Date:  2009-08-26       Impact factor: 2.563

10.  Enhancing endosomal escape of transduced proteins by photochemical internalisation.

Authors:  Kevin Mellert; Markus Lamla; Klaus Scheffzek; Rainer Wittig; Dieter Kaufmann
Journal:  PLoS One       Date:  2012-12-21       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.